Infusion Pump System, Accessories and Software Market is Growing at a Significant Rate in the Forecast Period 2017-2024

Global Infusion Pump system, Accessories and Software Market is expected to reach USD 14.31 billion by 2024 from USD 9.12 billion in 2016, at a CAGR of 5.8% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Access Full Report: 

Segmentation: Infusion Pump System, Accessories and Software Market 

By Type {Infusion Pump Systems (Volumetric IP, Syringe IP, Ambulatory IP, Enteral IP, Insulin IP, Implantable IP, Chemotherapy IP, Anesthesia IP), Infusion Pump Accessories (Infusion Administration Sets, IV Sets, Needleless Connectors), Infusion Pump Management Software (Asset Management Modules, EMR Modules, Respiratory Monitoring Modules)}, By Application (General Infusion, Pain and Anesthesia Management, Insulin Infusion, Enteral Infusion, Chemotherapy), By End-User (Hospitals, Ambulatory, Home Healthcare, Clinics), By Geography (North America, Europe, APAC, South America, Middle East and Africa) 

Drivers: Infusion Pump System, Accessories and Software Market

Some of the major factors driving the market for infusion pump system, accessories and software market are increasing demand for ambulatory infusion pumps, rising incidence of chronic diseases, increasing pool of aging population, increasing number of surgical disorders impacting the growth of surgical procedures, and technological development.


Ambulatory infusion pumps were used for many laboratory animal researchers as it allows drug delivery in ambulatory animals which was not possible before. Ambulatory infusion pumps evolved into multiple therapy pumps that is programmed for various different types of infusions limiting their use in the laboratory animal market. The arrival of ambulatory infusion pumps with software communications gave the ability to get data more efficiently, to get the pump's history and it also helps in trouble shooting the problems with the infusion pumps.


In recent years, the prevalence of chronic diseases (such as cancer, diabetes, hormonal disorder, and many others) across the globe has increased considerably over a period of time. The rapidly increasing aging population and the subsequent rise in chronic conditions are major factors driving the demand for infusion pump system, accessories and software.


The growing geriatric population across the world is leading to the increase in the prevalence of chronic diseases such as arthritis, cancer, respiratory diseases, metabolic disorders, orthopaedic, cardiovascular, and other age-related diseases. The growing population as well as the pressure on the healthcare system is increasing the demand of care, services, and technologies are rising to prevent and treat chronic diseases at old age.


The study, from doctors at Johns Hopkins, suggests that medical errors kill more people than lower respiratory diseases like emphysema and bronchitis do. The medical mistakes are the third leading cause of death in the United States after heart disease and cancer. The analysis estimates that at least 251,454 deaths due to medical errors occur annually in the United States.


The infusion pump system, accessories and software technology market is expected to show significant growth in the coming years, due to various technological advancements and new product launches in order to improve the convenience and ease of administration.

Major Players: Infusion Pump System, Accessories and Software Market

Some of the major players operating in this market are Baxter,  Becton, Dickinson and Company (BD), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Hospira, Animas Corporation, Medtronic, Moog Inc., Smiths Group Plc., F. Hoffmann-La Roche Ltd, Terumo Europe NV, Canè S.p.A, Caesarea Medical Electronics, Halyard Health, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd.,, ZOLL Medical Corporation., tricumed Medizintechnik GmbH, Teleflex Incorporated, ICU Medical, Inc., Novo Nordisk A/S, AngioDynamics, and Micrel Medical Devices.